These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 34910612)

  • 21. The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
    Chen ZB; Shen SQ; Ding YM; Wang WX; Tao JP; Liang LJ; Hu WJ
    Med Oncol; 2009; 26(3):365-71. PubMed ID: 19082771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
    Chai ZT; Kong J; Zhu XD; Zhang YY; Lu L; Zhou JM; Wang LR; Zhang KZ; Zhang QB; Ao JY; Wang M; Wu WZ; Wang L; Tang ZY; Sun HC
    PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
    Huang B; Huang M; Li Q
    Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
    Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
    Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma.
    Cheng S; Zhang X; Xu Y; Dai X; Li J; Zhang T; Chen X
    Sci Rep; 2018 Nov; 8(1):17415. PubMed ID: 30479372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis.
    Ao J; Qiang N; Kanzaki H; Nakamura M; Kakiuchi R; Zhang J; Kojima R; Koroki K; Inoue M; Kanogawa N; Nakagawa R; Kondo T; Ogasawara S; Nakamoto S; Muroyama R; Kato J; Kato N
    Am J Physiol Cell Physiol; 2024 Oct; 327(4):C1150-C1161. PubMed ID: 39250819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.
    Sunami Y; Ringelhan M; Kokai E; Lu M; O'Connor T; Lorentzen A; Weber A; Rodewald AK; Müllhaupt B; Terracciano L; Gul S; Wissel S; Leithäuser F; Krappmann D; Riedl P; Hartmann D; Schirmbeck R; Strnad P; Hüser N; Kleeff J; Friess H; Schmid RM; Geisler F; Wirth T; Heikenwalder M
    Hepatology; 2016 May; 63(5):1592-607. PubMed ID: 26892811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.
    Wang HC; Huang W; Lai MD; Su IJ
    Cancer Sci; 2006 Aug; 97(8):683-8. PubMed ID: 16863502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
    Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
    Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication.
    Kunanopparat A; Issara-Amphorn J; Leelahavanichkul A; Sanpavat A; Patumraj S; Tangkijvanich P; Palaga T; Hirankarn N
    World J Gastroenterol; 2018 Sep; 24(34):3861-3870. PubMed ID: 30228780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
    Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
    Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression.
    He L; Li H; Li C; Liu ZK; Lu M; Zhang RY; Wu D; Wei D; Shao J; Liu M; Wei HL; Zhang C; Wang Z; Kong LM; Chen ZN; Bian H
    Cancer Commun (Lond); 2023 Sep; 43(9):981-1002. PubMed ID: 37405956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
    Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
    Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
    Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
    Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
    Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
    PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
    Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
    J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.